Solitary Pulmonary Nodule
25
0
2
6
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.0%
4 terminated out of 25 trials
60.0%
-26.5% vs benchmark
4%
1 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (25)
Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
The Watch the Spot Trial
Confocal Laser Endomicroscopy Guided Cryobiopsy in the Diagnosis of Interstitial Lung Disease
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
iNod™ Ultrasound-Guided Needle Biopsy System Study
Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Evaluation of the Archimedes ™ System for Transparenchymatous Access to Pulmonary Nodules.
iNod System Human Feasibility Assessment
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography
Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions
Feasibility of Multi-Energy Digital Radiography Detector for Lung Lesions Detection
A Multi-Center Trial of the ProLung Test™
4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China
Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT
Tubeless VATS for Peripheral Lung Nodule
Clinical Study of Three Plus Two Type Early Diagnosis of Pulmonary Nodules in Medical Internet of Things